86 related articles for article (PubMed ID: 6697959)
1. Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity.
Scammell JG; Dannies PS
Endocrinology; 1984 Mar; 114(3):712-6. PubMed ID: 6697959
[TBL] [Abstract][Full Text] [Related]
2. Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
Scammell JG; Burrage TG; Eisenfeld AJ; Dannies PS
Endocrinology; 1985 Jun; 116(6):2347-54. PubMed ID: 3996317
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of cysteamine in depleting prolactin immunoreactivity.
Sagar SM; Millard WJ; Martin JB; Murchison SC
Endocrinology; 1985 Aug; 117(2):591-600. PubMed ID: 3926458
[TBL] [Abstract][Full Text] [Related]
4. Cysteamine induces depletion of both immunological and biological prolactin activity in the anterior pituitary and blood of the rat.
Millard WJ; Sagar SM; Simpkins JW; Owens RE; Badger TM; Friesen HG; Martin JB
Endocrinology; 1983 Dec; 113(6):2161-7. PubMed ID: 6641630
[TBL] [Abstract][Full Text] [Related]
5. Cysteamine depletes prolactin (PRL) but does not alter the structure of PRL-containing granules in the anterior pituitary.
Weinstein LA; Landis DM; Sagar SM; Millard WJ; Martin JB
Endocrinology; 1984 Oct; 115(4):1543-50. PubMed ID: 6479101
[TBL] [Abstract][Full Text] [Related]
6. Cysteamine-induced depletion of somatostatin and prolactin.
Millard WJ; Sagar SM; Martin JB
Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
[TBL] [Abstract][Full Text] [Related]
7. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
Parsons JA; Peterson EK; Hartfel MA
Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy of cysteamine in depleting prolactin immunoreactivity in different hyperprolactinemic animal models.
Millard WJ; Romano TM
Life Sci; 1991; 49(22):1635-42. PubMed ID: 1943468
[TBL] [Abstract][Full Text] [Related]
9. Depletion of bovine pituitary prolactin by cysteamine involves a thiol:disulfide mechanism.
Lorenson MY; Jacobs LS
Endocrinology; 1984 Oct; 115(4):1492-5. PubMed ID: 6479100
[TBL] [Abstract][Full Text] [Related]
10. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
Seo H; Refetoff S; Fang VS
Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
[TBL] [Abstract][Full Text] [Related]
11. Prolactin release-inhibitory effects of progesterone, megestrol acetate, and mifepristone (RU 38486) by cultured rat pituitary tumor cells.
Lamberts SW; van Koetsveld P; Verleun T
Cancer Res; 1987 Jul; 47(14):3667-71. PubMed ID: 3594432
[TBL] [Abstract][Full Text] [Related]
12. Cysteamine depletes prolactin in young and old hyperprolactinemic rats.
Simpkins JW; Estes KS; Millard WJ; Sagar SM; Martin JB
Endocrinology; 1983 May; 112(5):1889-91. PubMed ID: 6832077
[TBL] [Abstract][Full Text] [Related]
13. Regulation of prolactin secretion by dopamine and thyrotropin-releasing hormone in lactating rat adenohypophyses: influence of intracellular age of the hormone.
Mena F; Clapp C; Aguayo D; Morales MT; Grosvenor CE; MartÃnez de la Escalera G
Endocrinology; 1989 Oct; 125(4):1814-20. PubMed ID: 2507284
[TBL] [Abstract][Full Text] [Related]
14. Depletion and release of prolactin from rat pituitaries and pituitary tumors in vitro.
Kendall ME; Lawson DM
Proc Soc Exp Biol Med; 1988 Dec; 189(3):291-6. PubMed ID: 3205881
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.
Maas DL; Meier DA; Wahle JS; Martinson DR; Hagen TC
Mol Cell Neurosci; 1994 Apr; 5(2):182-8. PubMed ID: 8032686
[TBL] [Abstract][Full Text] [Related]
16. Thiol regulation of depletion-transformation and release of prolactin by the pituitary of the lactating rat.
Mena F; Clapp C; Aguayo D; Lorenson MY; Martinez-Escalera G
Endocrinology; 1986 May; 118(5):1795-802. PubMed ID: 3698895
[TBL] [Abstract][Full Text] [Related]
17. Reversal by thiols of dopamine-, stalk-median eminence-, and zinc-induced inhibition of prolactin transformation in adenohypophyses of lactating rats.
Martinez-Escalera G; Clapp C; Morales MT; Lorenson MY; Mena F
Endocrinology; 1986 May; 118(5):1803-7. PubMed ID: 3698896
[TBL] [Abstract][Full Text] [Related]
18. The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release.
Anthony PK; Stoltz RA; Pucci ML; Powers CA
Endocrinology; 1993 Feb; 132(2):806-14. PubMed ID: 8425495
[TBL] [Abstract][Full Text] [Related]
19. Cysteamine inhibition of bovine pituitary secretory granule prolactin immunoassayability and release.
Lorenson MY
Endocrinology; 1984 Aug; 115(2):728-35. PubMed ID: 6745176
[TBL] [Abstract][Full Text] [Related]
20. 17-beta-estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo.
Visser-Wisselaar HA; Van Uffelen CJ; Van Koetsveld PM; Lichtenauer-Kaligis EG; Waaijers AM; Uitterlinden P; Mooy DM; Lamberts SW; Hofland LJ
Endocrinology; 1997 Mar; 138(3):1180-9. PubMed ID: 9048625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
